# Safety, Tolerability and Immunogenicity of Fluzone® With and Without JVRS-100 in Elderly Subjects

> **NCT00936468** · PHASE2 · COMPLETED · sponsor: **Colby Pharmaceutical Company** · enrollment: 472 (actual)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** Fluzone® vaccine with JVRS-100 adjuvant or Fluzone alone

## Key facts

- **NCT ID:** NCT00936468
- **Lead sponsor:** Colby Pharmaceutical Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09
- **Primary completion:** 2010-06
- **Final completion:** 2010-09
- **Target enrollment:** 472 (ACTUAL)
- **Last updated:** 2011-02-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00936468

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00936468, "Safety, Tolerability and Immunogenicity of Fluzone® With and Without JVRS-100 in Elderly Subjects". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT00936468. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*